Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours
Open Access
- 1 December 1995
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (6) , 1474-1478
- https://doi.org/10.1038/bjc.1995.532
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Tumor tissue oxygenation as evaluated by computerized-po2-histographyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Bioreductive drugs and the selective induction of tumour hypoxiaBritish Journal of Cancer, 1990
- DOSE-DEPENDENT EFFECTS OF HYDRALAZINE ON MICROCIRCULATORY FUNCTION AND HYPERTHERMIC RESPONSE OF MURINE FSALL TUMORS1990
- Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agentsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1989
- P-31 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY STUDIES OF TUMOR ENERGY-METABOLISM AND ITS RELATIONSHIP TO INTRACAPILLARY OXYHEMOGLOBIN SATURATION STATUS AND TUMOR HYPOXIA1988
- Effects of Hydralazine-Induced Vasodilation on the Energy Metabolism of Murine Tumors Studied by In Vivo31P-Nuclear Magnetic Resonance Spectroscopy1JNCI Journal of the National Cancer Institute, 1988
- Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogsEuropean Journal of Cancer and Clinical Oncology, 1982
- Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1980